Da. Gelber et al., COMPONENTS OF VARIANCE FOR VIBRATORY AND THERMAL THRESHOLD TESTING INNORMAL AND DIABETIC SUBJECTS, Journal of diabetes and its complications, 9(3), 1995, pp. 170-176
Quantitative sensory testing (QST) is commonly used in the assessment
of diabetic neuropathy. However, little data are available on the reli
ability of tactile and thermal testing devices. Reproducibility of QST
measures between centers has not been previously reported. This study
was designed to validate QST testing procedures and determine if thes
e devices are suitable for large scale multicenter clinical trials. Fi
nger and toe vibratory (V-f, V-t) and thermal (T-f, T-t) thresholds we
re determined for ten normal individuals by a two-alternative forced-c
hoice procedure using the Optacon Tactile Tester (OTT) and Thermal Sen
sitivity Tester (TST). Threshold measurements were reproducible betwee
n technologists and had a day-to-day coefficient of variation of V-f 2
0%, V-t 23%, T-f 41%, and T-t 95%. Thresholds were determined for 140
normal individuals at six centers. Mean threshold values between cente
rs were not significantly different. Center-to-center coefficents of v
ariation (CV) were V-f 44%, V-t 45%, T-f 47%, and T-t 87%. There was n
o significant difference in threshold measures with regard to sex, sid
e studied, presence of calluses, or skin temperature. V-f thresholds s
ignificantly correlated with age (p < 0.01). There was no correlation
between either vibratory or thermal thresholds in normal individuals,
and nerve conduction velocities (NCV). Thermal and vibratory threshold
s were determined for 98 diabetic patients. Diabetic subjects without
clinical evidence of neuropathy were not significantly different from
normal individuals, but diabetic patients with neuropathy had increase
d thresholds compared to normals (p < 0.05). We conclude that thermal
and vibratory threshold testing with the OTT and TST yields reproducib
le measurements in normal individuals and provides an objective measur
e of clinical diabetic neuropathy that is well suited for multicenter
trials.